';

About us

Founded on the combination of cutting-edge synthetic biology and computational biology, Moirai Biodesign is putting RNA design at the service of biomedicine.

We envision our technologies and expertise as the catalysts of a healthcare ecosystem where rapid and affordable diagnostic methods are an option for all patients worldwide.

Our Team

Image
Amadís Pagès
Co-Founder and CEO
Image
Ivan Dotu
Co-founder and CTO
Image
Daniel Poglayen
Co-founder and CPDO
Image
Cristina Alsina
Research Scientist
Image
Judit Domingo
Product Developer
Image
Gerard Minuesa
Research Scientist

News

General Shareholders Extraodinary Meeting 2023

Moirai Biodesign’s General Shareholders Extraordinary Meeting will be held on January, 31st, at 11:00h. Please find the agenda here. Please find the proxy here (english / spanish)

More
General Shareholders Extraodinary Meeting 2022

Moirai Biodesign’s General Shareholders Extraordinary Meeting will be held on December, 23rd, at 10:00h. Please find the agenda here. Please find the proxy here (english / spanish)

More
General Shareholders Meeting 2022 – Update 2

Moirai Biodesign’s General Shareholders Meeting will be held on July, 22nd, at 10:00h. Please find the agenda here.

More
General Shareholders Meeting 2022 – Update 1

Moirai Biodesign’s General Shareholders Meeting is suspended due to agenda issues. Please find the official communication here.

More
General Shareholders Meeting 2022

Moirai Biodesign’s General Shareholders Meeting will be held on June, 27th, at 10:00h. Please find the agenda here.

More
General Shareholders Meeting 2021

Moirai Biodesign’s General Shareholders Meeting will be held on June, 28th, at 10:30h. Please find the agenda here.

More